Aerovate Therapeutics Stock Price History
| AVTE Stock | USD 21.60 0.90 4.00% |
If you're considering investing in Aerovate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aerovate Therapeutics stands at 21.60, as last reported on the 19th of April, with the highest price reaching 22.44 and the lowest price hitting 20.96 during the day. Aerovate Therapeutics appears to be not too volatile, given 3 months investment horizon. Aerovate Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0492, which signifies that the company had a 0.0492% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aerovate Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Aerovate Therapeutics' Mean Deviation of 4.32, risk adjusted performance of 0.0414, and Downside Deviation of 5.15 to double-check if our risk estimates are consistent with your expectations.
At present, Aerovate Therapeutics' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 12.5 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 98.2 M. . At present, Aerovate Therapeutics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 5.72, whereas Price Earnings To Growth Ratio is forecasted to decline to (0.23). Aerovate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Aerovate |
Sharpe Ratio = 0.0492
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AVTE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.69 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Aerovate Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aerovate Therapeutics by adding it to a well-diversified portfolio.
Price Book 6.4251 | Book Value 3.943 | Enterprise Value 505.2 M | Enterprise Value Ebitda (7.15) | Shares Float 10.1 M |
Aerovate Therapeutics Stock Price History Chart
There are several ways to analyze Aerovate Stock price data. The simplest method is using a basic Aerovate candlestick price chart, which shows Aerovate Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | April 1, 2024 | 30.75 |
| Lowest Price | January 26, 2024 | 17.68 |
Aerovate Therapeutics April 19, 2024 Stock Price Synopsis
Various analyses of Aerovate Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aerovate Stock. It can be used to describe the percentage change in the price of Aerovate Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aerovate Stock.| Aerovate Therapeutics Price Action Indicator | (0.55) | |
| Aerovate Therapeutics Price Rate Of Daily Change | 0.96 | |
| Aerovate Therapeutics Price Daily Balance Of Power | (0.61) |
Aerovate Therapeutics April 19, 2024 Stock Price Analysis
Aerovate Stock Price History Data
The price series of Aerovate Therapeutics for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 has a statistical range of 13.07 with a coefficient of variation of 15.57. The prices are distributed with arithmetic mean of 23.0. The median price for the last 90 days is 23.08.| Open | High | Low | Close | Volume | ||
04/19/2024 | 22.44 | 22.44 | 20.96 | 21.60 | ||
| 04/18/2024 | 22.44 | 22.44 | 20.96 | 21.60 | 216,299 | |
| 04/17/2024 | 23.97 | 23.97 | 21.81 | 22.50 | 159,191 | |
| 04/16/2024 | 24.85 | 25.58 | 23.47 | 23.62 | 132,905 | |
| 04/15/2024 | 25.34 | 25.35 | 24.27 | 25.30 | 106,784 | |
| 04/12/2024 | 26.64 | 27.11 | 24.44 | 25.24 | 133,112 | |
| 04/11/2024 | 26.59 | 27.10 | 26.53 | 26.89 | 142,551 | |
| 04/10/2024 | 26.51 | 27.79 | 26.22 | 27.01 | 223,391 | |
| 04/09/2024 | 26.41 | 28.70 | 26.41 | 28.05 | 132,128 | |
| 04/08/2024 | 25.40 | 26.58 | 24.51 | 26.48 | 119,804 | |
| 04/05/2024 | 28.00 | 28.00 | 24.43 | 25.05 | 246,273 | |
| 04/04/2024 | 29.62 | 30.29 | 28.77 | 29.10 | 153,814 | |
| 04/03/2024 | 29.00 | 30.25 | 28.23 | 29.12 | 179,635 | |
| 04/02/2024 | 29.16 | 29.97 | 28.45 | 29.58 | 169,299 | |
| 04/01/2024 | 30.43 | 32.42 | 28.29 | 30.75 | 295,752 | |
| 03/28/2024 | 29.01 | 29.99 | 27.10 | 29.57 | 216,915 | |
| 03/27/2024 | 27.39 | 29.36 | 25.62 | 28.50 | 922,350 | |
| 03/26/2024 | 26.55 | 27.32 | 24.27 | 25.65 | 271,347 | |
| 03/25/2024 | 26.51 | 28.39 | 26.26 | 26.95 | 224,601 | |
| 03/22/2024 | 26.00 | 26.78 | 25.40 | 25.78 | 90,513 | |
| 03/21/2024 | 26.19 | 27.00 | 25.69 | 26.00 | 188,545 | |
| 03/20/2024 | 25.61 | 27.34 | 25.36 | 25.89 | 102,950 | |
| 03/19/2024 | 26.07 | 26.97 | 25.07 | 25.72 | 100,094 | |
| 03/18/2024 | 26.75 | 27.12 | 25.24 | 26.39 | 191,434 | |
| 03/15/2024 | 24.41 | 27.37 | 24.41 | 26.70 | 105,613 | |
| 03/14/2024 | 26.87 | 26.87 | 23.95 | 24.29 | 75,160 | |
| 03/13/2024 | 24.17 | 27.82 | 23.06 | 26.98 | 104,171 | |
| 03/12/2024 | 24.67 | 25.20 | 23.28 | 24.14 | 302,231 | |
| 03/11/2024 | 26.35 | 26.35 | 24.13 | 24.77 | 124,970 | |
| 03/08/2024 | 24.50 | 27.20 | 23.52 | 26.52 | 105,084 | |
| 03/07/2024 | 24.13 | 25.85 | 23.46 | 24.40 | 143,654 | |
| 03/06/2024 | 22.96 | 24.10 | 22.96 | 23.87 | 41,983 | |
| 03/05/2024 | 22.11 | 23.22 | 22.06 | 22.84 | 44,281 | |
| 03/04/2024 | 23.96 | 23.96 | 22.42 | 22.49 | 51,022 | |
| 03/01/2024 | 23.11 | 24.24 | 22.21 | 23.83 | 108,483 | |
| 02/29/2024 | 23.75 | 24.17 | 22.33 | 23.08 | 51,983 | |
| 02/28/2024 | 23.43 | 24.19 | 22.22 | 23.09 | 51,375 | |
| 02/27/2024 | 21.21 | 24.49 | 19.99 | 23.77 | 163,560 | |
| 02/26/2024 | 19.36 | 21.63 | 18.08 | 20.74 | 70,687 | |
| 02/23/2024 | 18.81 | 20.10 | 18.81 | 19.63 | 82,065 | |
| 02/22/2024 | 18.62 | 19.20 | 18.39 | 18.82 | 95,812 | |
| 02/21/2024 | 18.69 | 19.44 | 18.11 | 18.85 | 184,675 | |
| 02/20/2024 | 20.47 | 21.01 | 18.04 | 18.80 | 219,186 | |
| 02/16/2024 | 21.62 | 22.28 | 20.81 | 20.91 | 80,254 | |
| 02/15/2024 | 19.49 | 21.69 | 18.47 | 21.64 | 65,784 | |
| 02/14/2024 | 19.38 | 19.86 | 18.08 | 19.25 | 43,059 | |
| 02/13/2024 | 19.43 | 20.35 | 18.69 | 19.00 | 90,466 | |
| 02/12/2024 | 21.00 | 22.20 | 20.09 | 20.40 | 91,608 | |
| 02/09/2024 | 20.34 | 22.20 | 20.34 | 21.45 | 88,185 | |
| 02/08/2024 | 20.81 | 22.00 | 18.99 | 20.53 | 61,240 | |
| 02/07/2024 | 19.98 | 21.06 | 19.51 | 20.59 | 52,401 | |
| 02/06/2024 | 17.95 | 20.23 | 17.95 | 19.97 | 50,628 | |
| 02/05/2024 | 17.44 | 18.50 | 16.95 | 18.14 | 53,519 | |
| 02/02/2024 | 18.27 | 18.48 | 16.74 | 17.95 | 140,816 | |
| 02/01/2024 | 19.28 | 19.50 | 18.25 | 18.69 | 62,916 | |
| 01/31/2024 | 19.00 | 20.64 | 18.82 | 19.31 | 70,545 | |
| 01/30/2024 | 17.87 | 19.08 | 17.87 | 18.83 | 56,646 | |
| 01/29/2024 | 17.71 | 18.33 | 17.41 | 18.10 | 97,949 | |
| 01/26/2024 | 18.50 | 19.00 | 17.05 | 17.68 | 182,826 | |
| 01/25/2024 | 19.36 | 19.99 | 18.01 | 18.35 | 703,835 | |
| 01/24/2024 | 20.68 | 20.68 | 18.70 | 19.15 | 81,697 |
About Aerovate Therapeutics Stock history
Aerovate Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aerovate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aerovate Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aerovate Therapeutics stock prices may prove useful in developing a viable investing in Aerovate Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.3 M | 27.3 M | |
| Net Loss | -20.7 M | -19.7 M |
Aerovate Therapeutics Quarterly Net Working Capital |
|
Aerovate Therapeutics Stock Technical Analysis
Aerovate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Aerovate Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aerovate Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aerovate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aerovate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0414 | |||
| Jensen Alpha | 0.1342 | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | 0.0438 | |||
| Treynor Ratio | 0.111 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aerovate Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Aerovate Stock analysis
When running Aerovate Therapeutics' price analysis, check to measure Aerovate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aerovate Therapeutics is operating at the current time. Most of Aerovate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aerovate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aerovate Therapeutics' price. Additionally, you may evaluate how the addition of Aerovate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Aerovate Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aerovate Therapeutics. If investors know Aerovate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aerovate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.87) | Return On Assets (0.39) | Return On Equity (0.64) |
The market value of Aerovate Therapeutics is measured differently than its book value, which is the value of Aerovate that is recorded on the company's balance sheet. Investors also form their own opinion of Aerovate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aerovate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aerovate Therapeutics' market value can be influenced by many factors that don't directly affect Aerovate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aerovate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aerovate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aerovate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.